BC Week In Review | Apr 23, 2007
Clinical News

Biocysan: Phase III start

Next month, the partners will begin a Mexican Phase III trial of oral Biocysan in 100 patients. Daxley licensed Latin American rights to Biocysan from Bio3. Bio3 Research s.r.l. , Milan, Italy   Daxley Group S.A....
Items per page:
1 - 1 of 1